Skip to main content
. 2022 Nov 24;23(4):61–72. doi: 10.1038/s41397-022-00297-1

Table 2.

The intersection of top 50 drugs by activity (Method 1) and connectivity (Method 2) scores on FOXM1 pathway.

Drug name Dose (µM) Na Rank by Activity score (Method 1) Connectivity score (Method 2)
Activity score difference (ASd)b Connectivity score Treatment (ASt) Control (ASc) Difference (ASd)
5109870 25 1 1 10 −8.57 1.59 −10.16 −0.66
MG-132 21 1 2 1 −4.45 1.97 −6.42 −1
MG-262 0.1 1 4 3 −2.95 1.79 −4.74 −0.83
Celastrol 2.5 1 5 7 −2.99 1.59 −4.58 −0.72
Resveratrol 50 2 6 8 0.92 5.2 −4.28 −0.7
Ciclopirox 15 2 7 37 −2.45 1.53 −3.98 −0.59
Pyrvinium 3.4 2 11 2 −1.85 1.56 −3.41 −0.84
Emetine 7.2 2 13 14 −1.37 1.71 −3.08 −0.63
15-delta prostaglandin J2 10 8 14 11 −1.18 1.73 −2.91 −0.66
Cephaeline 6 3 15 32 −0.95 1.96 −2.91 −0.6
Puromycin 7.4 2 16 17 −0.94 1.89 −2.84 −0.62
Parthenolide 16.2 2 23 18 −1.43 1.03 −2.46 −0.62
Azacitidine 16.4 2 24 49 −0.87 1.53 −2.39 −0.57
Cycloheximide 14.2 2 28 45 −0.3 2 −2.29 −0.57
Astemizole 8.8 2 29 27 0.04 2.3 −2.26 −0.6
5224221 12 2 36 25 −1.42 0.61 −2.03 −0.6
Scriptaid 10 1 42 20 1.32 3.29 −1.97 −0.62
Ouabain 5.4 2 43 30 −0.34 1.63 −1.97 −0.6
Bepridil 10 2 49 13 0.12 2 −1.88 −0.63

aThe number of experiments.

bActivity difference (ASd) = activity score in treatment (ASt) − activity score in control (ASc).